
95.06 Delayed Data As of Aug 12 | ![]() Today’s Change | 70.73 Today|||52-Week Range 97.76 | +7.59% Year-to-Date |
The 20 analysts offering 12-month price forecasts for Biomarin Pharmaceutical Inc have a median target of 114.50, with a high estimate of 174.00 and a low estimate of 70.00. The median estimate represents a +20.45% increase from the last price of 95.06.
The current consensus among 23 polled investment analysts is to Buy stock in Biomarin Pharmaceutical Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.